Abstract
This article discusses chemotherapy of neuroendocrine gut and pancreatic tumors and carcinoid tumors. Single-agent and combination chemotherapy in malignant carcinoid tumors are reviewed, as is chemotherapy of endocrine pancreatic tumors and liver-targeted chemotherapy. Future prospects for the use of chemotherapy are included.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Endocrinology and metabolism clinics of North America
Paper Title
Journal
Date
